1 University Avenue Macquarie University NSW 2109 AUSTRALIA www.cochlear.com ASX Announcement 13 November 2026 Cochlear hosts Capital Markets Day, reaffirms FY27 guidance and announces departure of President, North America Cochlear Limited (ASX: COH) reaffirms its FY27 guidance of low single-digit...
CMD details, CNA leader change & FY27 guidance reaffirmed
Filed with ASX · · 134 pages · English
Summary by 6ix AI
Cochlear Limited's filing reports on its Capital Markets Day, reaffirming guidance for revenue growth and announcing the departure of its North America President. The company expects low single-digit sales growth and highlights the importance of developed market cochlear implants as a key growth driver. Cochlear also outlines strategies to expand access to treatment and improve referral pathways for adult cochlear implant candidates. The announcement emphasizes the need for increased awareness and medicalization of hearing loss to drive growth in the cochlear implant market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
In the deck
Earlier from Cochlear
- 2026 AGM Results
- 2026 AGM Chair and CEO & President Addresses
- Ceasing to be a substantial holder
- Notification of cessation of securities - COH
- Notification regarding unquoted securities - COH
Later from Cochlear
All Cochlear news releasesFollow Cochlear into a list and get an email when it puts out news.
Follow Cochlear